Drug development showcasing at AACR conference
April 13, 2015Research and Development, Sales and Marketing American Association of Cancer Research, AstraZeneca, Bayer, Genentech, Novartis, aacr
This month’s American Association of Cancer Research conference is set to showcase the latest studies in oncology. Roche’s biotech subsidiary …
AstraZeneca diabetes drug could ‘significantly’ increase mortality
April 13, 2015Research and Development, Sales and Marketing AstraZeneca, FDA, Nesina, Onglyza, Takeda, alogliptin, cardiovascular, saxagliptin
AstraZeneca’s diabetes drug Onglyza may lead to a ‘significant increase’ in risk of death according to a new analysis from …
E-clinical: the rise of new health technologies
April 13, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, NHS, apps, digital, eHealth, eyeforpharma, kelsey, pharma, wearables
In the UK the NHS is generally considered to be traditionally resistant to new technology, but it has been forced …
Bioinformatics pioneer joins 23andMe from Genentech
April 13, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 23andME, Genentech, Robert Gentleman
California-based personal genetics firm 23andMe has appointed Robert Gentleman to be its vice president of computational biology. The company is …
Novo Nordisk opens insulin plant in Russia
April 10, 2015Manufacturing and Production, Sales and Marketing Novo Nordisk, Russia, diabetes, flexpen, insulin, kaluga, penfill
Denmark’s Novo Nordisk has opened a new manufacturing facility in Russia to produce more of its diabetes offerings in the …
Pfizer launches cardiovascular research competition
April 10, 2015Research and Development, Sales and Marketing Amgen, Astellas, LDL, PCSK9, Pfizer, bococizumab, inhibitors
Pfizer is funding a new competitive grants programme to support research projects in the burgeoning, competitive area of cholesterol-lowering PCSK9 …
Eisai cuts 25% of US staff
April 10, 2015Medical Communications, Research and Development, Sales and Marketing Daiichi, Eisai, US, cuts, layoffs, reorganisation, staff
Eisai’s US business is offloading around 200 jobs as part of some restructuring to create a more ‘efficient and focussed …
Shire gets FDA boost – but suffers trial setback
April 10, 2015Research and Development, Sales and Marketing FDA, Shire, algs, lifitegrast, shp625
Shire has achieved mixed results in its attempts to get regulatory approval for two new treatments – bagging a priority …
RSA hires senior consultant
April 10, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Kris Richards, rsa
Life sciences executive search and interims specialist firm RSA has appointed a new senior consultant to its executive interims team. …
Over one billion drugs dispensed in England in 2014, NHS report shows
April 9, 2015Sales and Marketing HSCIC, NHS, drug cost, net ingredient cost, prescribing, prescription cost analysis, prescriptions
Patients in England collected over 1.1 billion prescription items in 2014, according to NHS figures. Statistics from the Health and …
Merck and Pfizer to co-promote cancer drug
April 9, 2015Research and Development, Sales and Marketing Cancer, Merck, Merck KGaA, NSCLC, Pfizer, Xalkori, non-small cell lung cancer, oncology
Merck KgaA and Pfizer have agreed to co-promote the latter’s lung cancer treatment Xalkori, and form a new alliance that …
Former FDA commissioner named as Institute of Medicine foreign secretary
April 9, 2015Manufacturing and Production, Medical Communications, Research and Development Dr Margaret Hamburg, FDA, IOM, Institute of Medicine, Margaret Hamburg
Former commissioner of the US Food and Drug Administration Margaret Hamburg has been appointed as the next foreign secretary of …
Cello Health Consulting gains senior marketer
April 8, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cello, beverly hope, consulting, health
Healthcare strategic marketing consultancy Cello Health Consulting has appointed pharma marketer Beverly Hope as a senior consultant for its brand and portfolio …
Gilead’s next-generation HIV drug to be FDA assessed
April 8, 2015Research and Development, Sales and Marketing F/TAF, FDA, Gilead, HIV, Tenofovir Alafenamide, emtricitabine
Gilead Sciences has filed its second new drug application for a new combination HIV treatment with the FDA.The California-based company …
Amgen’s colorectal cancer drug EU approved
April 8, 2015Sales and Marketing Amgen, Vectibix, ibrutinib, imbruvica, panitumumab, ristempa
The European Commission has shown Amgen’s cancer drug Vectibix the green light to treat patients in combination with chemotherapy for …
FDA to look again at Novo Nordisk insulin submissions
April 8, 2015Research and Development, Sales and Marketing Novo Nordisk, Ryzodeg, Tresiba, diabetes, insulin degludec
Diabetes specialist firm Novo Nordisk has resubmitted its applications for two insulins to the FDA, along with new interim safety …
EU nod for Roche cancer drug and chemotherapy
April 8, 2015Sales and Marketing Cancer, Roche, avastin, bevacizumab, cervical, chemotherapy, wet AMD
The European Commission has approved Roche’s Avastin in combination with standard chemotherapy for women with advanced cervical cancer. Avastin (bevacizumab) …
Vaxon Biotech appoints founder as chief executive
April 8, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Konstantinos Kosmatopoulos, vaxon biotech
Paris-based Vaxon Biotech has announced its founder Dr Konstantinos Kosmatopoulos is moving from his current role as chief scientific officer …
Takeda expands in the United Arab Emirates
April 7, 2015Medical Communications, Sales and Marketing Dubai, NEMEA, Singapore, Takeda, UAE, United Arab Emirates, near east
Takeda has opened new UAE offices in Dubai amidst plans to expand its business in the Middle East. The Japanese …
Latest content
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine
